Close Menu

NEW YORK – LifeSpan BioSciences said this week that it has acquired Everest Biotech, which specializes in the production of antigen affinity purified goat polyclonal antibodies. The acquisition will expand LSBio's offering of more than 500,000 monoclonal and polyclonal primary antibodies, the company said. Financial terms of the acquisition were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

At a meeting this week, researchers and others discussed the regulatory oversight needed for germline genome editing.

The US Food and Drug Administration has asked questions about Myriad Genetics' GeneSight test, according to Bloomberg.

Researchers report that neutrophil extracellular traps appear to binds gallstones together, according to New Scientist.

In Science this week: approach to infer genotype-by-environment interaction from genetic variants associated with phenotypic variability, and more.